Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

Objectives: Alzheimer's disease (AD) is a serious neurodegenerative disease. Although
many therapeutic strategies have been studied, their clinical applications are immature …

The members of the genus Sideritis have a wide variety of phytochemicals and thus the
genus are gaining interest to fabricate nanoparticles (via green synthesis) as sources …

Alzheimer's disease (AD) is the most common cause of dementia in the elderly, clinically
defined by progressive cognitive decline and pathologically, by brain atrophy …

Alzheimer's disease (AD), Parkinson's disease (PD), and depression are growing burdens
for society globally, partly due to a lack of effective treatments. Mangosteen (Garcinia …

Neurodegenerative diseases (NDs) are considered public health problem characterized by
neural loss causing cognitive and behavioral impairments. It is currently possible to use …

Alzheimer's disease (AD), as a neurodegenerative disorder, usually develops slowly but
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …

Combining diagnosis with therapy, magnetic iron oxide nanoparticles (INOPs) act as an
important vehicle for drug delivery. However, poor biocompatibility of INOPs limits their …

The blood–brain barrier (BBB) is a protective barrier for brain safety, but it is also a major
obstacle to the delivery of drugs to the cerebral parenchyma such as the hippocampus …

Alzheimer's disease (AD) is a kind of neuropsychiatric illness that affects the central nervous
system. In this disease, the accumulation of amyloid-beta increases, and phosphorylated tau …